Immunology Assays
A comprehensive in vitro platform to accelerate cancer immunotherapy drug discovery:
- Binding & blocking assessment (via biophysical and biochemical assays, and flow cytometry)
- Immune cell activation (T cell, B cell, and NK cells)
- Immune cell suppression (MDSC and Treg suppressive assays)
- Immune T cell polarization and macrophage differentiation
- Antigen presentation/mixed lymphocyte reaction (including mouse allogenic splenocytes, DC co-cultures with T cells )
- in vitro cytotoxicity assay (including ADCC, ADCP, and CDC)
Check out our comprehensive platform of immunology services
Immunology Services
Related Content
NK cells are effector innate lymphoid cells (ILCs) that do not require antigen-specific priming. NK cells are not only killer...
VIEW RESOURCEJoin WuXi AppTec at IMMUNOLOGY2024™. For this year’s annual meeting of the American Association of Immunologists (AAI), WuXi Biology has...
VIEW RESOURCE